GlassScriptPhysician profile
Patrick Martin-Tuite
NPI 1598409039
$3,423.67
in general payments reported to CMS, 2019-2025
10 companies · $2,654 in 2025
The $2,654 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $770 · 2025: $2,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Travel and Lodging: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.26 |
| Travel and Lodging | $1,078.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,616.83 | 2024-2025 | Accolade Sr, General - Erectile Dysfunction, Lithovue |
| Calyxo, INC. | $186.41 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $139.30 | 2024 | Axonics, Bulkamid |
| Urogen Pharma, INC. | $125.00 | 2025 | |
| Janssen Scientific Affairs, LLC | $121.02 | 2025 | Erleada |
| Baxter Healthcare | $100.26 | 2025 | Seprafilm |
| Karl Storz Endoscopy-America | $54.68 | 2024 | N.A. |
| Medtronic, INC. | $44.57 | 2025 | Interstim |
| Olympus America INC. | $18.75 | 2025 | Uretero-Reno Videoscope |
| Endo USA, INC. | $16.85 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Martin-Tuite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.